Work is ongoing in the following areas:
- Development of nanoparticle based immunotherapies for drug sensitive and drug resistant forms of tuberculosis
- Development of inhalable particles for treatment of tuberculosis
- Studies of the interaction of nanoparticles and immune cells in the context of infectious diseases
- Synthesis and evaluation of nanoparticles for infectious diseases drug delivery